Verdad Advisers, LP

Position in VTRS — Viatris Inc

CIK 1812822 BOSTON, MA

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$439,075

-$370,175 QoQ

Shares Held

32,500

-50.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Verdad Advisers, LP holds $1,326,696 across 4 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (33.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc This page	32,500	$439,075
2	SUPN	Supernus Pharmaceuticals, Inc.	6,295	$325,388
3	ASRT	Assertio Holdings, Inc.	15,541	$296,211
4	BIOA	BioAge Labs, Inc.	15,210	$266,022

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$439,075	32,500	-50.0%	Shares	Sole	2026-05-15
2025-12-31	$809,250	65,000	+8.3%	Shares	Sole	2026-02-17
2024-09-30	$696,600	60,000	-20.0%	Shares	Sole	2024-11-14
2024-06-30	$797,250	75,000	0.0%	Shares	Sole	2024-08-06
2024-03-31	$895,500	75,000	-6.8%	Shares	Sole	2024-05-14
2023-12-31	$871,815	80,500	+46.4%	Shares	Sole	2024-02-09
2023-09-30	$542,300	55,000	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.